CQ’s Carey Discusses Medicare Prescription Drug Price Negotiation Bill; Stem Cell Legislation; FDA Drug Safety, User …



Wednesday, April 25th, 2007

Mary Agnes Carey, associate editor of CQ HealthBeat, examines Senate rejection of legislation that would allow the federal government to negotiate Medicare prescription drug prices, Senate approval of a bill that would expand stem cell research funding and House and Senate discussions on FDA reauth [click link for full article]

Read the rest: Read more here…



Previous Tax Provision Would Reduce Medicare Payments To Providers

Next  Congress Should Eliminate Subsidies For Medicare Advantage Plans, Editorial States